The approval for the insurance benefit of ‘Nexavar’… the birth of the only treatment of thyroid cancer

‘Nexavar’, a well-known drug for liver cancer, will be permitted to be prescribed for thyroid cancer patients.

After the review of the Cancer Deliberation Committee last month, the Health Insurance Review & Assessment Service recently revised the ‘detailed matters for application standards and methods of treatment benefits regarding medication prescribed to cancer patients’ and established the...